Showing results (281-290 of 344) with videos related to
Sort By:
Pageof 35
Blood|June 25, 2017
Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphomaTomoko Narita, Takashi Ishida, Asahi Ito, et al.International Journal of Hematology|November 25, 2024
Clinical significance of NOTCH1 and FBXW7 alterations in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.Cancer Science|February 26, 2018
Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myelomaShinsuke Iida, Masashi Wakabayashi, Kunihiro Tsukasaki, et al.Nature Communications|May 3, 2022
IRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphomaStella Amanda, Tze King Tan, Jolynn Zu Lin Ong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2020
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 TrialMeletios A Dimopoulos, Ivan Špička, Hang Quach, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2015
[Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma]Ayako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.The Journal of Investigative Dermatology|November 30, 2016
MiR-142 Is Required for Staphylococcus aureus Clearance at Skin Wound Sites via Small GTPase-Mediated Regulation of the Neutrophil Actin CytoskeletonKatsuya Tanaka, Sang Eun Kim, Hiroki Yano, et al.International Journal of Hematology|February 15, 2023
A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphomaTomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, et al.Cancer Science|September 25, 2020
Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy studyKazutaka Sunami, Kenshi Suzuki, Masaki Ri, et al.Cancer Science|February 26, 2016
Lenalidomide and low-dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II studyKenshi Suzuki, Atsushi Shinagawa, Toshiki Uchida, et al.Pageof 35